0001140361-19-018071.txt : 20191007
0001140361-19-018071.hdr.sgml : 20191007
20191007191559
ACCESSION NUMBER: 0001140361-19-018071
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191007
FILED AS OF DATE: 20191007
DATE AS OF CHANGE: 20191007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coiante Scott M
CENTRAL INDEX KEY: 0001608536
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39069
FILM NUMBER: 191141663
MAIL ADDRESS:
STREET 1: 101 POOR FARM ROAD 3RD FLOOR
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781983
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6095104718
MAIL ADDRESS:
STREET 1: 535 BOYLSTON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
form4.xml
FORM 4
X0306
4
2019-10-07
0001781983
Aprea Therapeutics, Inc.
APRE
0001608536
Coiante Scott M
535 BOYLSTON STREET
BOSTON
MA
02116
true
SVP, Chief Financial Officer
Common Stock
2019-10-07
4
P
0
2500
15
A
2500
D
Stock Option (right to Buy)
15
2019-10-07
4
A
0
150824
0
A
2029-10-02
Common Stock
150824
150824
D
Twenty-five percent of these options vest on October 2, 2020, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.
/s/ Scott M. Coiante
2019-10-07